Hayashi Eye Hospital, Fukuoka, Japan.
Cornea. 2013 Jul;32(7):1019-25. doi: 10.1097/ICO.0b013e31827c0b76.
To compare the longitudinal changes in corneal endothelial cell density (ECD) and the incidence of postoperative complications between eyes with endothelial decompensation after repeat penetrating keratoplasty (RPK) and those after primary penetrating keratoplasty (PPK).
Fifty-seven eyes with endothelial decompensation scheduled for RPK (RPK group) and 57 eyes with endothelial decompensation scheduled for PPK (PPK group) were enrolled. Corneal ECD was evaluated using a specular microscope at 1, 3, 6, 9, and 12 months, and every 6 months until 60 months postoperatively. Visual acuity (VA) and incidence of graft failure, graft rejection, or marked increase in intraocular pressure were examined.
Corneal ECD decreased gradually and percentage of cell loss at 60 months was approximately 73% in both groups; these did not differ significantly between groups throughout the follow-up (P ≥ 0.2209). The incidence of graft failure (52.6% in the RPK group and 36.8% in the PPK group), immune rejection, and marked increase in intraocular pressure did not differ significantly between groups (P ≥ 0.0898), although corrected VA was worse in the RPK group. The most common cause of graft failure in both groups was late endothelial failure. The outcomes were not significantly different between eyes that underwent a first RPK and those that underwent a second or subsequent RPK.
Corneal endothelial cell loss and complications are comparable between eyes with endothelial decompensation after RPK and those after PPK, although VA is worse in eyes after RPK. The outcomes after a first RPK did not differ from those after multiple RPKs.
比较重复穿透性角膜移植(RPK)后和初次穿透性角膜移植(PPK)后角膜内皮失代偿眼的角膜内皮细胞密度(ECD)的纵向变化和术后并发症的发生率。
纳入 57 例计划行 RPK(RPK 组)和 57 例计划行 PPK(PPK 组)的角膜内皮失代偿眼。使用共焦显微镜于术后 1、3、6、9 和 12 个月及此后每 6 个月评估角膜 ECD,直至术后 60 个月。检查视力(VA)和移植物失功、排斥或眼内压显著升高的发生率。
两组角膜 ECD 均逐渐下降,60 个月时细胞丢失率约为 73%;整个随访过程中两组间无显著差异(P≥0.2209)。RPK 组和 PPK 组的移植物失功发生率(52.6%和 36.8%)、免疫排斥和眼内压显著升高的发生率无显著差异(P≥0.0898),尽管 RPK 组的矫正视力(VA)更差。两组中最常见的移植物失功原因是晚期内皮失代偿。首次 RPK 和第二次或多次 RPK 后眼的结果无显著差异。
RPK 后和 PPK 后角膜内皮失代偿眼的角膜内皮细胞丢失和并发症相当,尽管 RPK 后眼的 VA 更差。首次 RPK 的结果与多次 RPK 后无显著差异。